XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Cash, Cash Equivalents, and Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2023
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Investments
The following table shows the Company’s cash, cash equivalents, and marketable securities by significant investment category as of March 31, 2023 and December 31, 2022:
As of March 31, 2023
Adjusted CostAllowance for Credit Losses Total Unrealized GainsTotal Unrealized LossesFair ValueCash and Cash EquivalentsMarketable Securities
(in thousands)
Cash$191,390 $— $— $— $191,390 $191,390 $— 
Level 1:
Money market funds40,931 — — — 40,931 40,931 — 
Subtotal40,931 — — — 40,931 40,931 — 
Level 2:
U.S. treasury securities75,162 — — (151)75,011 — 75,011 
Subtotal75,162 — — (151)75,011 — 75,011 
Total$307,483 $— $— $(151)$307,332 $232,321 $75,011 

As of December 31, 2022
Adjusted CostAllowance for Credit Losses Total Unrealized GainsTotal Unrealized LossesFair ValueCash and Cash EquivalentsMarketable Securities
(in thousands)
Cash$155,459 $— $— $— $155,459 $155,459 $— 
Level 1:
Money market funds69,484 — — — 69,484 69,484 — 
Subtotal69,484 — — — 69,484 69,484 — 
Level 2:
U.S. treasury securities74,659 — — (403)74,256 — 74,256 
Subtotal74,659 — — (403)74,256 — 74,256 
Total$299,602 $— $— $(403)$299,199 $224,943 $74,256